Domestic cats are the definitive host of Toxoplasma gondii and are one source of T. gondii infection in human populations, along with consumption of undercooked or cured contaminated meats and vertical transmission during the prenatal and perinatal period [1,2]. Contact with cats or cat faeces may increase the risk of T. gondii infection [3,4], although this has not been not found in all studies [5,6].
Thomas et al. recently compared national statistics on the prevalence of antibodies to T. gondii infection (seroprevalence ranging from 4% to 67%) with incidence of brain cancer. After adjustment for gross domestic product, sex, mobile phone use and latitude, they found that there was a correlation between the prevalence of antibodies to T. gondii and the incidence of brain cancer [7]. They estimated that there was a 1.8-fold increase in brain cancer incidence in countries with the highest prevalence of T. gondii antibodies, compared with countries with the lowest prevalence.
We have used data from a large UK prospective cohort of middle-aged women to investigate the relationship between cat ownership and incidence of brain tumours. Information on current ownership of cats, dogs, birds and fishes was obtained from a postal survey of study participants during 2006–2007: the respondents to this survey form the baseline cohort for these analyses. Full details of the study design and methods are described elsewhere [8], and all questionnaires can be viewed at http://www.millionwomenstudy.org. Information on T. gondii positivity or consumption of undercooked meats was not available.
In total, 626 454 women aged 64 years on average at baseline were included in the analyses, among whom, 114 614 (18%) owned at least one cat. Table 1 shows the characteristics of the study population by cat ownership. Women who owned a cat as a pet were slightly younger, slightly less likely to be in the upper third of socio-economic status, and more likely to be current smokers and have ever used hormone replacement therapy than women who did not have a pet.
Table 1.
Characteristics of the study population by cat ownership and details of follow-up including relative risks (RRs) and 95% CIs for central nervous system (CNS) tumour incidence.
| own no pets | own cat(s) | own cat(s) onlya | own cat and other petsa | |
|---|---|---|---|---|
| number of women | 378 066 | 114 614 | 78 825 | 35 789 |
| mean age (s.d.) | 64.8 (4.9) | 63.4 (4.5) | 63.4 (4.5) | 63.4 (4.5) |
| socio-economic group (% in upper third) | 34.2 | 32.9 | 33.3 | 31.9 |
| mean height, cm (s.d.) | 162.2 (6.6) | 162.7 (6.7) | 162.6 (6.7) | 162.7 (6.8) |
| mean body mass index, kg m−2 (s.d.) | 26.3 (4.7) | 26.6 (4.9) | 26.5 (4.9) | 26.7 (5.0) |
| strenuous physical activity > 1 h week−1 (%) | 54.5 | 56.2 | 55.2 | 58.6 |
| alcohol intake, ≥70 g week−1 (%) | 29.4 | 31.5 | 31.8 | 30.9 |
| current smoker (%) | 7.6 | 9.4 | 9.3 | 9.6 |
| ever used hormone replacement therapy (%) | 51.9 | 56.6 | 56.5 | 56.7 |
| follow-up for CNS tumours | ||||
| women-years of follow-up (1000s) | 1189.9 | 365.3 | 251.2 | 114.1 |
| average years of follow-up per woman | 3.15 | 3.19 | 3.19 | 3.19 |
| incident CNS tumours (n) | 292 | 79 | 54 | 25 |
| incident brain cancersb (n) | 159 | 41 | 25 | 16 |
| incident gliomas (n) | 123 | 30 | 18 | 12 |
| incident meningiomas (n) | 71 | 21 | 14 | 7 |
| RR and 95% CIs for CNS tumour incidence | ||||
| all CNS tumours | 1 | 0.90 (0.70–1.15) | 0.89 (0.67–1.20) | 0.90 (0.60–1.36) |
| all brain cancersb | 1 | 0.88 (0.62–1.24) | 0.78 (0.51–1.19) | 1.09 (0.65–1.83) |
| glioma | 1 | 0.86 (0.58–1.29) | 0.75 (0.46–1.23) | 1.11 (0.61–2.01) |
| meningioma | 1 | 0.96 (0.58–1.56) | 0.92 (0.51–1.63) | 1.05 (0.48–2.29) |
aA subgroup of ‘own cat(s)’ with or without other pets.
bICD-10 C70-72, as classed by Thomas et al. [7].
Cancer registrations for the entire population are routinely notified to the study investigators through the National Health Service Central Registers. This information includes the date of each such event and codes the tumour site and morphology using the 10th revision of the International Classification of Diseases (ICD-10) [9]. We calculated relative risks (RRs) and 95% confidence intervals (CIs) for incidence of all tumours of the central nervous system (CNS) (ICD-10 C70, C71, C72.0, C75.1-3, D32, D33, D35.2-4, D42, D43 and D44.3-5), of brain cancer (ICD-10 C70-72) as defined by Thomas et al., and of specified glioma and meningioma in relation to cat ownership using a Cox proportional hazards model with attained age as the underlying time variable. Analyses were stratified by region and by quintiles of socio-economic status, and we adjusted for height, body mass index, hormone replacement therapy use, daily alcohol intake and weekly strenuous exercise. We were unable to assess whether the risk of brain cancer varied with age (as suggested by Vittecoq et al. [10] for brain cancer mortality) owing to the low number of incident cases aged over 64 years.
Eligible women contributed woman-years from the date that they answered the baseline questions about living with a cat until the date of diagnosis with the tumour of interest, date of death, diagnosis of another cancer (except non-melanoma skin cancer) or the end of follow-up, whichever was earliest. During 2 million person-years of follow-up (an average of 3.2 years per woman), 494 CNS tumours were reported, of which 265 were brain tumours as classed by Thomas et al.
Incidence of brain cancer was not increased in women living with a cat (RR = 0.88, 95% CI = 0.62–1.24), when compared with women living with no pets. Similarly, no association was observed for all CNS tumours, or for specified glioma or meningioma (table 1). In conclusion, cat owners in a cohort of middle-aged UK women do not have an increased risk of brain cancer, when compared with non-cat owners. This, however, does not rule out the possibility that T. gondii infection from another source may be associated with brain cancer incidence.
Acknowledgements
This study was funded by Cancer Research UK, the Medical Research Council and the UK National Health Service Breast Screening Programme.
Footnotes
The accompanying reply can be viewed at http://dx.doi.org/doi:10.1098/rsbl.2012.0625.
References
- 1.Innes E. A. 2010. A brief history and overview of Toxoplasma gondii. Zoonoses Public Health 57, 1–7 10.1111/j.1863-2378.2009.01276.x (doi:10.1111/j.1863-2378.2009.01276.x) [DOI] [PubMed] [Google Scholar]
- 2.Dubey J. P., Jones J. L. 2008. Toxoplasma gondii infection in humans and animals in the United States. Int. J. Parasitol. 38, 1257–1278 10.1016/j.ijpara.2008.03.007 (doi:10.1016/j.ijpara.2008.03.007) [DOI] [PubMed] [Google Scholar]
- 3.Liu Q., et al. 2009. Toxoplasma gondii infection in pregnant women in China. Trans. R. Soc. Trop. Med. Hyg. 103, 162–166 10.1016/j.trstmh.2008.07.008 (doi:10.1016/j.trstmh.2008.07.008) [DOI] [PubMed] [Google Scholar]
- 4.Kapperud G., Jenum P. A., Stray-Pedersen B., Melby K. K., Eskild A., Eng J. 1996. Risk factors for Toxoplasma gondii infection in pregnancy: results of a prospective case-control study in Norway. Am. J. Epidemiol. 144, 405–412 10.1093/oxfordjournals.aje.a008942 (doi:10.1093/oxfordjournals.aje.a008942) [DOI] [PubMed] [Google Scholar]
- 5.Cook A. J. C., Gilbert R. E., Buffolano W., Zufferey J., Petersen E., Jenum P. A., Foulon W., Semprini A. E., Dunn D. T. 2000. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. Br. Med. J. 321, 142–147 10.1136/bmj.321.7254.142 (doi:10.1136/bmj.321.7254.142) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Flegr J., Hrdá S., Tachezy J. 1998. The role of psychological factors in questionnaire-based studies on routes of human toxoplasmosis transmission. Cent. Eur. J. Public Health 6, 45–50 [PubMed] [Google Scholar]
- 7.Thomas F., Lafferty K. D., Brobeur J., Elguero E., Gauthier-Clerc M., Missé D. 2011. Incidence of adult brain cancers is higher in countries where the protozoan parasite Toxoplasma gondii is common. Biol. Lett. 8, 101–103. (doi:10.1098/rsbl.2011.0588) [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.Benson V. S., Pirie K., Green J., Bull D., Casabonne D., Reeves G. K., Beral V. 2010. Hormone replacement therapy and incidence of central nervous system tumours in the Million Women Study. Int. J. Cancer 127, 1692–1698 10.1002/ijc.25184 (doi:10.1002/ijc.25184) [DOI] [PubMed] [Google Scholar]
- 9.World Health Organization. 1992. International classification of diseases, 10th revision, vol. 1. Geneva, Switzerland: World Health Organisation.
- 10.Vittecoq M., Elguero E., Lafferty K. D., Roche B., Brodeur J., Gauthier-Clerc M., Missé D., Thomas F. 2012. Brain cancer mortality rates increase with Toxoplasma gondii seroprevalence in France. Infect. Genet. Evol. 12, 496–498 10.1016/j.meegid.2012.01.013 (doi:10.1016/j.meegid.2012.01.013) [DOI] [PubMed] [Google Scholar]
